Novavax’s Covid Vaccine Is Authorized in Europenews2021-12-21T04:57:33+00:00December 21st, 2021|The New York Times|
Senators Question Califf, the F.D.A. Nominee, on Opioid Crisis and Pandemic Responsenews2021-12-14T23:44:00+00:00December 14th, 2021|The New York Times|
Merck’s Covid Pill Might Pose Risks for Pregnant Womennews2021-12-13T15:27:03+00:00December 13th, 2021|The New York Times|
F.D.A. Authorizes AstraZeneca Drug for People With Immune Problemsnews2021-12-08T23:03:55+00:00December 8th, 2021|The New York Times|
Los nuevos antivirales para la covid ofrecen esperanza frente a la variante ómicronnews2021-12-08T15:49:42+00:00December 8th, 2021|The New York Times|
New Covid Antiviral Pills Offer Hope as Omicron Loomsnews2021-12-07T08:00:09+00:00December 7th, 2021|The New York Times|
The Variant Hunters: Inside South Africa’s Effort to Stanch Dangerous Mutationsnews2021-12-04T18:53:12+00:00December 4th, 2021|The New York Times|
Will High Vaccination Rates Help Spain Weather Omicron?news2021-12-02T18:14:26+00:00December 2nd, 2021|The New York Times|
Omicron Is Here. Will We Use Our New Covid Drugs Wisely?news2021-12-01T23:11:37+00:00December 1st, 2021|The New York Times|
Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panelnews2021-12-01T00:23:13+00:00December 1st, 2021|The New York Times|